[Effect of heparin and epsilon-aminocaproic acid on the development of experimental arteriosclerosis].
D000614:Aminocaproates / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000473:pathology; D001161:Arteriosclerosis / Q000139:chemically induced / Q000150:complications / Q000209:etiology* / Q000473:pathology; D001777:Blood Coagulation / Q000187:drug effects; D001835:Body Weight; D005234:Fatty Liver / Q000150:complications; D005342:Fibrinolysis / Q000187:drug effects; D006493:Heparin / Q000494:pharmacology*; D006529:Hepatomegaly / Q000150:complications; D008099:Liver / Q000033:anatomy & histology / Q000473:pathology; D009929:Organ Size; D011817:Rabbits
D000614:Aminocaproates; D006493:Heparin
Vliianie geparina i epsilon-aminokapronovoĭ kisloty na razvitie éksperimental'nogo ateroskleroza.